GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Eris Lifesciences Ltd (BOM:540596) » Definitions » Sale Of Investment

Eris Lifesciences (BOM:540596) Sale Of Investment : ₹0 Mil (TTM As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Eris Lifesciences Sale Of Investment?

Eris Lifesciences's sale of investment for the three months ended in Dec. 2023 was ₹0 Mil. It means Eris Lifesciences gained ₹0 Mil from selling investments. Eris Lifesciences's sale of investment for the trailing twelve months (TTM) ended in Dec. 2023 was ₹0 Mil.

Compared with last quarter (₹0 Mil in Sep. 2023 ), Eris Lifesciences gained the same money from selling investments in Dec. 2023 (₹0 Mil).


Eris Lifesciences Sale Of Investment Historical Data

The historical data trend for Eris Lifesciences's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eris Lifesciences Sale Of Investment Chart

Eris Lifesciences Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Sale Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only 797.30 3,260.79 774.20 795.87 5,204.39

Eris Lifesciences Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Sale Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Eris Lifesciences Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Eris Lifesciences Sale Of Investment Related Terms

Thank you for viewing the detailed overview of Eris Lifesciences's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


Eris Lifesciences (BOM:540596) Business Description

Traded in Other Exchanges
Address
Ramdas Road, Plot No. 142/2, Shivarth Ambit, Off SBR, Near Swati Bungalows, Bodakdev, Ahmedabad, GJ, IND, 380054
Eris Lifesciences Ltd is an India-based company engaged in the manufacturing and sale of branded pharmaceutical formulations. It focuses on Lifestyle therapies such as Diabetes Care, Cardiac Care, Nutrition, Central Nervous System, and others. The company operates in a single segment that is pharmaceuticals. Some of its brands include Glimisave, Cyblex, Eritel, Atorsave and Crevast.

Eris Lifesciences (BOM:540596) Headlines

No Headlines